Behcet's Disease — Research Summary
Printed from RareWays (rareways.com.au) on 5 April 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Incidence and Prevalence of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis.
Sriranganathan Aswen et al. — Retina (Philadelphia, Pa.) (3 March 2026)
https://pubmed.ncbi.nlm.nih.gov/41791034/
- 2.
Are there disparities in cerebral sinus venous thrombosis between the Arab and Jewish populations in Israel - a multicenter cohort study?
Molad Jeremy et al. — Journal of the neurological sciences (27 February 2026)
https://pubmed.ncbi.nlm.nih.gov/41807916/
- 3.
Exploratory whole-exome sequencing identifies candidate DNA variants in Ocular Behcet disease: a pilot study from a Pakistani cohort.
Waqas Ayesha et al. — Ophthalmic genetics (23 February 2026)
https://pubmed.ncbi.nlm.nih.gov/41730713/
- 4.
Retinal thickness and microvascular alterations in the diagnosis of behcet's disease: a case-control study.
Xing Zheng-Mao et al. — BMC medical imaging (19 February 2026)
https://pubmed.ncbi.nlm.nih.gov/41715012/
- 5.
A rare constellation: Behcet's disease, moyamoya syndrome, and recurrent ostial coronary occlusions.
Celik Aziz Inan et al. — Coronary artery disease (4 February 2026)
https://pubmed.ncbi.nlm.nih.gov/41635136/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Recruiting — Phase 2 — NS Pharma, Inc.
https://clinicaltrials.gov/study/NCT05996003
- 2.
AutoInflammatory Disease Alliance Registry (AIDA)
Recruiting — University of Siena
https://clinicaltrials.gov/study/NCT05200715
- 3.
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Recruiting — Phase 1 — Chugai Pharmaceutical
https://clinicaltrials.gov/study/NCT06371417
- 4.
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Recruiting — Sanford Health
https://clinicaltrials.gov/study/NCT01793168
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Behcet's Disease
Behcet's disease is a rare systemic vasculitis causing recurrent oral ulcers, genital ulcers, eye inflammation, and skin lesions. It is more prevalent in people from the Middle East, Turkey, and East Asia. Treatment depends on which organs are affected, with immunosuppressants and newer biologics increasingly used.
Most Recent Research
PURPOSE: To estimate the incidence and prevalence of non-infectious uveitis (NIU). METHODS: A systematic literature search was conducted of electronic databases including Ovid Medline, Embase, and Scopus from 2020 to September 2025. A random-effects meta-analysis pooled incidence and prevalence data across various demographic and comorbid contexts. RESULTS: From 15,172 initial studies, 106 were included. The pooled prevalence of NIU was 131.6 (95% CI 28.1-613.9) for adults and 27.4 (95% CI 6.3-118.3) for pediatrics per 100,000 persons. Pooled incidence of NIU was 204.4 (95% CI 0.0-438.9) for adults and 16.0 (95% CI 6.5-25.6) for pediatrics per 100,000 person-years. Increased incidence and prevalence of NIU were seen in populations of Juvenile idiopathic arthritis (JIA), undifferentiated Spondyloarthritis (SpA), Psoriatic arthritis (PsA), Ankylosing spondylitis (AS), and Behcet disease (BD). Prevalence of NIU in JIA was 129.2 (95% CI 94.2-174.7) per 1,000 persons and incidence was 22.4 (95% CI 2.5-42.4) per 1,000 person-years. Prevalence and incidence of NIU in SpA was 153.5 (95% CI 122.0-191.4) per 1,000 persons and 33.5 (95% CI 0.0-69.2) per 1,000 person-years, respectively. Prevalence and incidence of NIU in PsA was 27.3 (95% CI 18.1-41.2) per 1,000 persons and 13.1 (95% CI 0.0-32.5) per 1,000 person-years, respectively. Prevalence of NIU in AS and BD was 183.5 (95% CI 137.8-240.1) and 148.6 (95% CI 17.6-629.9) per 1,000 persons, respectively. CONCLUSIONS: NIU incidence and prevalence were higher in adults than in children, and in populations with specific conditions like JIA and AS.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.